InfuSystem reports Q1 revenue up 5% to $32.0M; net loss widens, reaffirms guidance

InfuSystem Holdings, Inc

2024-Q1 EPS reported -$0.05 revenue$31,995,000

Net revenues of $32.0M (+5% YoY); record quarterly revenue.
Gross margin improved to 51.5% from 49.2%; gross profit +10%.
Net loss widened to $1.1M ($0.05/share) from $0.3M ($0.02) a year ago.
Adjusted EBITDA fell 9% to $3.9M, with margin of 12.1% vs 13.9%.
FY 2024 guidance reaffirmed: high-single-digit revenue growth, high-teens EBITDA margin.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

InfuSystem Holdings, Inc reported first quarter ended March 31, 2024 results: revenue Net revenues totaled $32.0 million, net income Net loss was $1.1 million, EPS $(0.05) per diluted share.

Period: first quarter ended March 31, 2024
Revenue: Net revenues totaled $32.0 million
Net income: Net loss was $1.1 million
EPS: $(0.05) per diluted share
Result: reported results

Exact text from the filing

• Net revenues totaled $32.0 million, an increase of 5% vs. prior year. ◦ Patient Services net revenue was $18.6 million, a decrease of 1% vs. prior year. ◦ Device Solutions net revenue was $13.4 million, an increase of 16% vs. prior year. • Gross profit was $16.5 million, an increase of 10% vs. prior year. • Gross margin was 51.5%, an increase of 2.3% vs. prior year. ◦ Patient Services gross margin was 66.0%, an increase of 4.5% vs. prior year. ◦ Device Solutions gross margin was 31.3%, an increase of 1.9% vs. prior year. • Net loss was $1.1 million, or $(0.05) per diluted share vs. prior year net loss of $0.3 million, or $(0.02) per diluted share.

View on SEC.gov

1052 earnings releases filed in the last 30 days. Browse all earnings releases →

InfuSystem Holdings, Inc filing history →

Source: SEC EDGAR

accession 0001628280-24-021926

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.